ALBANY, NY, FEB 27, 2017 : Single-stranded fragments of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) are called DNA probes and RNA probes respectively.These DNA and RNA probes are short in length (usually 100-1000 bases long) capable of forming highly specific, non-covalent duplexes with complementary sequence of nucleic acid strand. Therefore typical applications of these probes are in (fluorescence) in situ hybridization ((F)ISH), microarray-based gene expression profiling or electrophoretic mobility shift assays (EMSA).
These DNA and RNA genetic probes have three important applications from medical perspective; namely, detection of specific nucleic acid sequences, detection of changes in nucleic acid sequences(mutation) and detection of tandem repeat sequences (30-50 base pairs). Such probes are designed to detect and identify various infectious agents such as bacteria, protozoa and viruses. Detection of genetic mutation using DNA and RNA probe is also of diagnostic importance in hereditary diseases such as cystic fibrosis, muscular dystrophy, phenylketonuria and sickle cell anemia. The detection of tandem repeat sequences is of vital use in forensic science and paternity testing.
The DNA or RNA probes are categorized either as radioactive probes or as non-radioactive probes based on the nature of material used for labelling. Radioactive probes most commonly involve enzymatic incorporation of 32P, 33P, or 35S.Non-radioactive probesinvolve attaching the probe either to an enzyme (e.g., alkaline phosphatase or horseradish peroxidase), or to an antibody directed against an enzyme, or to a fluorephore, or to achemifluorescent substrate. Alternatively these probes can be labeled with biotin, making it detectable by a streptavidin/avidin-enzyme conjugate.
Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=186964
Some of the major players in the global DNA and RNA probes market are Amersham Life Science, Inc., Clontech Laboratories, Inc., Epicentre Technologies, FMC Corporation, GE Healthcare, Genosys Biotechnologies, Inc., IBA GmbH, IDEXX Laboratories, Inc., Kamiya Biomedical Co., Oncor, Inc., Operon, Inc., Sigma-Aldrich Co. LLC., Signet Laboratories, Inc., and Vysis, Inc.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market projections for upcoming years
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=186964
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
For More Information Kindly Contact:
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States – 12207
USA-Canada Toll Free: 866-997-4948
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://researchreportlife.blogspot.in//